your experience, are community pharmacies to promote medicines and pharmacies generally delivering these related services available to consumers? services? your experience, do community currently some programs that pharmacists provide appropriate advice are viewed as additional to dispensing for schedule 2 and 3 medicines? which should be included as part of the the current restrictions on the sale of service provided by a pharmacist when a schedule 2 and 3 medicines an prescription medicine is dispensed (for appropriate balance between access and example, a medicines check or review)? If health and safety for consumers? If not, so, how should pharmacists be how could this balance be improved? remunerated for providing these services? Should such services be the sale of schedule 2 and 3 medicines included each time a prescription is filled an important contributor to the income or should and ‘initial’ ‘repeat’ of community pharmacies? prescription dispensing involve different services? the availability and promotion of vitamins and complementary medicines there a variation in service standards in community pharmacies influence between different pharmacy models? consumer buying habits? community pharmacies that complementary products be discount medicines provide lower levels available at a community pharmacy, or of service? If so, what evidence is there does this create a conflict of interest for available to support this? pharmacists and undermine health care? do we measure the level of service consumers appreciate the provided by the pharmacy? convenience of having the availability of vitamins and complementary medicines do consumers expect from in one location? Do consumers benefit community pharmacy in relation to their from the advice (if any) provided by medicines? pharmacists when selling complementary the $1 discount had an impact on medicines? the access and affordability of PBS the environment’ within ‘retail medicines? Has the introduction of the which community pharmacy operates $1 discount been a successful detract from health care objectives? implementation of policy? the current consumer payments for examples can you provide of the supply and dispensing of PBS listed variation in prices for regular PBS medicines transparent? Are they prescriptions? appropriate? informed are consumers of the the PBS Safety Net adequate to of medicines and related services that address the needs of low income can be provided by pharmacists without consumers who face high referral to a General Practitioner? pharmaceutical costs and other what degree do current advertising costs? If not, what other restrictions limit the ability of strategies can be employed to ensure
your experience, are community pharmacies generally delivering these services? currently some programs that are viewed as additional to dispensing which should be included as part of the service provided by a pharmacist when a prescription medicine is dispensed (for example, a medicines check or review)? If so, how should pharmacists be remunerated for providing these services? Should such services be included each time a prescription is filled or should ‘initial’ and ‘repeat’ prescription dispensing involve different services? there a variation in service standards between different pharmacy models? community pharmacies that discount medicines provide lower levels of service? If so, what evidence is there available to support this? do we measure the level of service provided by the pharmacy? do consumers expect from community pharmacy in relation to their medicines? the $1 discount had an impact on the access and affordability of PBS medicines? Has the introduction of the $1 discount been a successful implementation of policy? examples can you provide of variation in prices for regular PBS prescriptions? informed are consumers of the of medicines and related services that can be provided by pharmacists without referral to a General Practitioner? what degree do current advertising restrictions limit the ability of pharmacies to promote medicines and related services available to consumers? your experience, do community pharmacists provide appropriate advice for schedule 2 and 3 medicines? the current restrictions on the sale of schedule 2 and 3 medicines an appropriate balance between access and health and safety for consumers? If not, how could this balance be improved? the sale of schedule 2 and 3 medicines an important contributor to the income of community pharmacies? the availability and promotion of vitamins and complementary medicines in community pharmacies influence consumer buying habits? complementary products be available at a community pharmacy, or does this create a conflict of interest for pharmacists and undermine health care? consumers appreciate the convenience of having the availability of vitamins and complementary medicines in one location? Do consumers benefit from the advice (if any) provided by pharmacists when selling complementary medicines? the ‘retail environment’ within which community pharmacy operates detract from health care objectives? the current consumer payments for the supply and dispensing of PBS listed medicines transparent? Are they appropriate? the PBS Safety Net adequate to address the needs of low income consumers who face high pharmaceutical costs and other costs? If not, what other strategies can be employed to ensure